ROYAL BANK OF CANADA

Bank

Position in MNPR — Monopar Therapeutics

CIK 1000275 TORONTO, A6

Position in MNPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,592

+$9,908 QoQ

Shares Held

136

+177.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#85

of 95 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. MNPR ranks #264 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,592	136	+177.6%	Shares	Defined	2026-08-14
2026-03-31	$2,684	49	-85.0%	Shares	Defined	2026-05-15
2025-12-31	$21,286	326	+334.7%	Shares	Defined	2026-02-17
2025-09-30	$6,124	75	+294.7%	Shares	Defined	2025-11-14
2025-06-30	$679	19	-90.7%	Shares	Defined	2025-11-21
2025-03-31	$7,464	205	+105.0%	Shares	Defined	2025-11-21
2024-03-31	$68	100	-98.0%	Shares	Defined	2024-11-05
2023-03-31	$6,950	5,000	+21.5%	Shares	Defined	2023-05-15
2022-06-30	$9,466	4,116	0.0%	Shares	Defined	2022-08-15
2022-03-31	$10,495	4,116	0.0%	Shares	Defined	2022-05-16
2021-12-31	$13,212	4,116	0.0%	Shares	Defined	2022-02-14
2021-09-30	$20,044	4,116	-19.8%	Shares	Defined	2021-11-15
2021-06-30	$30,215	5,130	-43.8%	Shares	Defined	2021-08-16
2021-03-31	$56,605	9,130	—	Shares	Defined	2021-07-20
No filing history on record for this holder in this stock.